{"document": {"publication": "Tag My News", "full_text": "amgen inc and takeda pharmaceutical co ltd said their experimental drug, motesanib, had failed to improve overall survival in a late-stage study of patients with advanced lung cancer.", "title": "amgen, takeda drug fails advanced lung-cancer study", "line_count": 1, "filename": "6069", "publication_date": "30-03-2011 14:24:38", "lines_and_colors": [["amgen inc and takeda pharmaceutical co ltd said their experimental drug, motesanib, had failed to improve overall survival in a late-stage study of patients with advanced lung cancer.", {}]]}}